McGlone Suttner Wealth Management Inc. Makes New $39,000 Investment in Henry Schein, Inc. (NASDAQ:HSIC)

McGlone Suttner Wealth Management Inc. purchased a new stake in Henry Schein, Inc. (NASDAQ:HSICFree Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 519 shares of the company’s stock, valued at approximately $39,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Everett Harris & Co. CA increased its stake in shares of Henry Schein by 29.1% in the 4th quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock valued at $7,925,000 after acquiring an additional 23,622 shares during the last quarter. Canvas Wealth Advisors LLC bought a new stake in Henry Schein during the 4th quarter worth approximately $613,000. Assenagon Asset Management S.A. increased its stake in Henry Schein by 13.3% in the 4th quarter. Assenagon Asset Management S.A. now owns 58,979 shares of the company’s stock valued at $4,465,000 after buying an additional 6,934 shares during the last quarter. Sendero Wealth Management LLC increased its stake in Henry Schein by 22.1% in the 4th quarter. Sendero Wealth Management LLC now owns 11,363 shares of the company’s stock valued at $860,000 after buying an additional 2,060 shares during the last quarter. Finally, Raymond James & Associates increased its stake in Henry Schein by 672.5% in the 4th quarter. Raymond James & Associates now owns 153,046 shares of the company’s stock valued at $11,587,000 after buying an additional 133,233 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HSIC. Evercore ISI lifted their price target on shares of Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research note on Wednesday, February 28th. StockNews.com downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Monday, December 4th. SVB Leerink started coverage on shares of Henry Schein in a research report on Monday, February 26th. They issued a “market perform” rating and a $78.00 price objective for the company. Barrington Research lifted their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Wednesday, February 28th. Finally, Piper Sandler lifted their price objective on shares of Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research report on Monday, February 26th. One analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company. According to MarketBeat, Henry Schein has an average rating of “Hold” and a consensus price target of $81.09.

Read Our Latest Research Report on HSIC

Henry Schein Stock Performance

Shares of HSIC stock opened at $75.52 on Friday. The company has a market capitalization of $9.70 billion, a price-to-earnings ratio of 23.97, a PEG ratio of 1.87 and a beta of 0.87. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. The company has a 50-day simple moving average of $75.23 and a 200 day simple moving average of $72.66. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $85.75.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). The business had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business’s revenue for the quarter was down 10.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.21 EPS. On average, sell-side analysts predict that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.